A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
This study is to compare and evaluate the safety and pharmacokinetic characteristics (PK)
after administration of SID1903 and SID1903-R1/SID1903-R2 in healthy adult volunteers.